The association between beta-blockers use and prostate cancer mortality: A mini systematic review and meta-analysis.
Alessandro UleriMichael BaboudjianAlessandro TeddePaweł RajwaBenjamin PradereAndrea GallioliAlberto BredaGuillaume PloussardPublished in: The Prostate (2023)
We found no association between beta-blockers use and overall survival or PCa mortality. This meta-analysis, which includes a considerable population and the most recent literature, provides important data for routine clinical care and patient counseling.
Keyphrases
- systematic review
- prostate cancer
- cardiovascular events
- angiotensin converting enzyme
- healthcare
- risk factors
- radical prostatectomy
- palliative care
- case report
- electronic health record
- meta analyses
- quality improvement
- smoking cessation
- clinical practice
- type diabetes
- angiotensin ii
- hiv testing
- men who have sex with men
- human immunodeficiency virus
- data analysis
- affordable care act
- antiretroviral therapy